Bangkok, March 30, 2023, 10 a.m. ICT – Today (March 30, 2023), at the Professor Donal O’Donoghue Global Kidney Policy Forum at the World Congress of Nephrology (WCN 2023) in Bangkok, Thailand, the International Society of Nephrology (ISN) presented the highlights from its third, 2023 edition of the ISN-Global Kidney Health Atlas (ISN-GKHA). A...
The latest #NephTrials online discussion took place on March 10. Access the Twitter thread here. Twitter attendees joined Ron Gansevoort, Roberto Pecoits-Filho, Joel Topf, Manasi Bapat, and Swapnil Hiremath to discuss the RENAL LIFECYCLE trial. The conversation examined the composite and secondary outcomes of a randomized control trial investigating the effects of dapagliflozin on people with severe...
Kidney International Editorial Selection Endemic Rise in Cases of Acute Kidney Injury in Children in Indonesia and Gambia: What is the Likely Culprit and Why? This report sheds light on the sudden rise in acute kidney injury (AKI) cases in Indonesia and Gambia. The increase has been linked to poor quality control in manufacturing syrup medications...
Watch the latest ISN video abstract from the @ISNeducation Social Media Team. Watch the video here. This video is based on a paper from Kidney International Reports: Antibody Guided Therapy In PLA2R-associated Membranous Nephropathy
The ISN-KI Early-Career Researcher (ECR) Award recognizes outstanding research in basic and clinical science published in Kidney International (KI) in 2022. The ISN-KI Editorial Fellowship, designed for early-career kidney care professionals, provides training opportunities for reviewing and evaluating manuscripts and managing editorial responsibilities for a world-renowned nephrology journal. The Editorial Fellows will train with the...
The ISN-ACT Global Trials Focus (GTF) is a monthly selection of recent interesting trials relevant to kidney care. Each month, one trial is spotlighted as the "trial of the month." Recent trials of the month include: Cooled Enthusiasm for Lower Dialysate Temperatures; No Demonstrated Benefit for Cardiovascular Outcomes Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers Show Reassuring...
The next #NephTrials will be held on March 10, 2023, at 3 p.m. CET! Join Ron Gansevoort, primary investigator of the RENAL LIFECYCLE trial, in conversation with Michael Walsh, Roberto Pecoits-Filho, Joel Topf, Manasi Bapat, and Swapnil Hiremath. The panel will examine the composite and secondary outcomes of a randomized control trial investigating the effects...
Almost 300 people joined ISN i3C (CKDu) Network members* and ISN Renal Pathology Working Group representative, Carmen Avila-Casado, to learn more about the dilemma facing clinicians working in chronic kidney disease of unknown etiology (CKDu) endemic areas: whether or not they should undertake a kidney biopsy in a person with suspected CKDu. Did you miss...
By Javier Neyra, ISN YNC member Over the past year, I've had the opportunity to lead efforts by the Capacity Building Sub-committee of the ISN Young Nephrology Committee (YNC). Young nephrologists worldwide have consistently highlighted the need to build capacity in research, particularly for those practicing in developing countries with limited scholarly resources. Therefore, one of...
Kidney International: Glomerular Diseases in Pregnancy: Pragmatic Recommendations for Clinical Management Glomerular diseases are a frequent cause of chronic kidney disease in young women and generate many challenges in pregnancy. An international working group reviews current literature and expert opinions on glomerular diseases in pregnancy to provide practical information for nephrologists. The authors highlight areas of clinical...
Did you miss the live session of the ISN Webinar "Mixed Methods Research in Kidney Care"? Watch the recording here. Moderators Fergus Caskey, Pippa Bailey, and Masaomi Nangaku joined speakers Alicia O’Cathain and Lilia Cervantes in an interactive discussion on mixing qualitative and quantitative research methods within a single kidney care study. The event generated much...
On behalf of the Australasian Kidney Trials Network Survey, patients, caregivers and health professionals are invited to complete a global survey to help identify important things to consider when preventing urine infections in people with kidney transplants. The answers will help design a clinical trial to attain better evidence. The survey takes 8-12 minutes to complete. Take...
The ISN-ACT (Advancing Clinical Trials) has created an online map tracking trial networks in kidney care research around the world. The aim is to facilitate clinical trial capacity and professional exchanges and collaboration by connecting people undertaking clinical trials and related studies in nephrology. The map allows researchers to quickly locate trial networks with the capacity...
"Availability and Prioritization of COVID-19 Vaccines Among Patients With Chronic Kidney Disease and Kidney Transplant - A Global Survey by the International Society of Nephrology" has been published in BMJ Open. Read the manuscript here. The paper is based on a survey initiated by a team of ISN members on the availability, preparation and prioritization of...
The manuscript “Challenges and Opportunities in Interventions for Chronic Kidney Disease of Unknown Origin (CKDu): Report from the International Society of Nephrology Consortium of Collaborators on CKDu” has been published in Kidney International. Read the manuscript here. The paper was drafted after a special ISN i3C Working Group meeting was held to discuss potential interventions in communities...
Defining Measures of Kidney Function In Observational Studies Using Routine Health Care Data: Methodological and Reporting Considerations This review illustrates the diversity of working definitions of kidney disease in scientific literature and discusses the advantages and limitations of the most commonly used approaches. The authors summarize ways to identify and overcome possible biases and propose a framework...
The ISN Clinical Research Program (CRP) offers grants to researchers in low, lower-middle, and upper-middle-income countries to support research projects on detecting and managing noncommunicable chronic diseases such as CKD, AKI, hypertension, diabetes, and cardiovascular disease. Apply to the program here. Regional coordinators must receive the application by April 1. Final applications are accepted once per...
Did you miss the live session? A recording is available here. Professor Meg Jardine, ISN-ACT (Advancing Clinical Trials) Committee chair, and speakers David Wheeler, Jonathan Barratt and Jodie Babitt joined in a lively discussion on this treatment option and on the management of anemia in CKD patients. This webinar is supported by Astellas.
Clockwise, from top left: Carinna Hockham, Anastasiia Zykova, Suman Behera and Mark Canney The ISN Executive Committee and Council have approved four “ISN-Named Fellows.” Please join us in congratulating Suman Behera from ISN I3C (CKDu), Mark Canney from ISN iNET-CKD (cohort studies), and Anastasiia Zykova and Carinna Hockham from ISN-ACT (clinical trials). Get to know our new ISN-Named Fellows here. These early-career ISN...
Kidney International Particulate Matter of Air Pollution May Increase Risk of Kidney Failure in IgA Nephropathy. Environmental pollution has been associated with the progression of chronic kidney disease in the general population. This study specifically investigated the influence of exposure to fine particulate matter less than 2.5 μm in diameter (PM2.5) on IgAN progression. Kidney International Reports Leveraging...
